Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report

Buprenorphine is increasingly used to treat pain in patients with sickle cell disease but optimal timing and approach for transitioning patients from full agonist opioids to buprenorphine is unknown. We present the case of a 22-year-old woman with sickle cell disease and acute on chronic pain who tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Leyde, Sarah, Suen, Leslie, Pratt, Lisa, DeFries, Triveni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Clinical Vignette
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971332/
https://www.ncbi.nlm.nih.gov/pubmed/34993878
http://dx.doi.org/10.1007/s11606-021-07295-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971332/
https://www.ncbi.nlm.nih.gov/pubmed/34993878
http://dx.doi.org/10.1007/s11606-021-07295-2

Ejemplares similares